Companies: 10,795·Total market cap: $144.5T
Evotec SE

Evotec SE

EVONASDAQHealthcare● Active
$2.82
+$0.02(+0.71%)
Market Cap$1.0B
P/E Ratio—
52W High$4.44
52W Low$2.31
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

Evotec SE (EVO) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001412558 · EVO · NASDAQ · as of Jun 8, 2026

Filing snapshot

180
Total Filings
6-K
Latest Form
2026-05-06
Most Recent
2004
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001412558 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-04-08
Fiscal Year End
Apr 8, 2026
Accession No.
0001104659-26-040767
Primary Document
evo-20251231x20f.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001412558 · Accession 0001104659-26-040767

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2026-05-06
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-05-06
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-05-01
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-30
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-24
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-08
View
20-FAnnual Report (Foreign Issuer)
FORM 20-F
2026-04-08
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-04-07
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-04-06
View
SCHEDULE 13DSCHEDULE 13D
SCHEDULE 13D
2026-03-30
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-03-10
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-02-17
View
SCHEDULE 13GSCHEDULE 13G
SCHEDULE 13G
2026-01-16
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-01-16
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-01-13
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2026-01-08
View
Showing 1–15 of 180 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001412558  |  Exchange: NASDAQ · Healthcare

Evotec SE (NASDAQ: EVO) has submitted 180 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2004. As a Healthcare sector company with CIK 0001412558, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Evotec SE's most comprehensive regulatory disclosure. The most recent Evotec SE 10-K was filed on 2026-04-08 for fiscal year ending 2026. Historical EVO 10-K annual reports are available from 2007 through 2026.

Investors researching Evotec SE SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
SYRE SEC Filings →PHVS SEC Filings →NVCR SEC Filings →TDOC SEC Filings →ALVO SEC Filings →HROW SEC Filings →SDGR SEC Filings →AZTA SEC Filings →
→ EVO Financials→ EVO Earnings→ EVO Insider Trades

Frequently Asked Questions

EVO SEC Filings · 8 questions

Evotec SE (EVO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 180 filings and access original documents at no cost. Evotec SE's CIK is 0001412558.

EVO SEC filingsEvotec SE SEC documentsfind EVO 10-K